Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance

被引:67
|
作者
Alric, L
Fort, M
Izopet, J
Vinel, JP
Bureau, C
Sandre, K
Charlet, JP
Beraud, M
Abbal, M
Duffaut, M
机构
[1] CHU Toulouse, Hop Purpan, Serv Med Interne, F-31059 Toulouse, France
[2] Hop Rangueil, Lab Macrophages Mediateurs Inflammat & Interact C, EA 2405, Toulouse, France
[3] Hop Rangueil, Immunol Lab, Toulouse, France
[4] Hop Purpan, Virol Lab, Toulouse, France
[5] Hop Purpan, Serv Hepatogastroenterol, Toulouse, France
[6] Hop Purpan, Federat Digest, Serv Epidemiol, Toulouse, France
来源
TISSUE ANTIGENS | 2000年 / 56卷 / 02期
关键词
HLA; host-response; genotype; HCV; viral-hepatitis; MHC class II; immunogenetic; hepatitis C virus; viral clearance;
D O I
10.1034/j.1399-0039.2000.560207.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Epidemiologic parameters, virologic characteristics and frequency of HLA class II: DR and DQ antigens were compared between 63 subjects with spontaneous hepatitis C virus clearance (group 1) and 282 patients with chronic active hepatitis C virus infection (group 2). DRB1*1101 and moreover DQB1*0301 alleles were more frequent in group 1 than in group 2 (33.8% vs. 14.7% and 64.4% vs. 28.6%; P=0.012 and P=0.003, respectively). The frequency of DQB1*02 was lower in group 1 than in group 2 (25.4% vs. 49%; P=0.04). No difference was observed in viral genotype distribution between group 1 and group 2. Univariate analysis showed that female sex and contamination by intravenous drug use were associated with self limited infection. However, by multivariate analysis, the only independent factor associated with hepatitis C virus RNA clearance was female sex (P=0.004). In conclusion, spontaneous hepatitis C virus RNA clearance is determined by class II antigens (mainly DQB1*0301) and female sex, while viral genotype plays no role.
引用
收藏
页码:154 / 158
页数:5
相关论文
共 50 条
  • [21] Reversibility of hepatitis C virus-related cirrhosis
    Pol, S
    Carnot, F
    Nalpas, B
    Lagneau, JL
    Fontaine, H
    Serpaggi, J
    Serfaty, L
    Bedossa, P
    Bréchot, C
    HUMAN PATHOLOGY, 2004, 35 (01) : 107 - 112
  • [22] Management of hepatitis C virus-related arthritis
    Palazzi, C
    Olivieri, I
    Cacciatore, P
    Pennese, E
    D'Amico, E
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (01) : 27 - 34
  • [23] Treatment of hepatitis C virus-related cirrhosis
    Bronowicki, JP
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2002, 26 : B220 - B224
  • [24] Management of hepatitis C virus-related arthritis
    Zuckerman, E
    Yeshurun, D
    Rosner, I
    BIODRUGS, 2001, 15 (09) : 573 - 584
  • [25] Hepatitis C virus-related skin diseases
    Doutre, MS
    ARCHIVES OF DERMATOLOGY, 1999, 135 (11) : 1401 - 1403
  • [26] Complex Association of Virus- and Host-Related Factors with Hepatocellular Carcinoma Rate following Hepatitis C Virus Clearance
    Akuta, Norio
    Suzuki, Fumitaka
    Sezaki, Hitomi
    Kobayashi, Masahiro
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Hosaka, Tetsuya
    Kobayashi, Mariko
    Saitoh, Satoshi
    Suzuki, Yoshiyuki
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    JOURNAL OF CLINICAL MICROBIOLOGY, 2019, 57 (01)
  • [27] Hepatitis C virus genotypes and clinical features in hepatitis C virus-related mixed cryoglobulinemia
    Origgi, L
    Vanoli, M
    Lunghi, G
    Carbone, A
    Grasso, M
    Scorza, R
    INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1998, 28 (02): : 96 - 99
  • [28] Spontaneous clearance of childhood hepatitis C virus infection
    Yeung, L. T. F.
    To, T.
    King, S. M.
    Roberts, E. A.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (11) : 797 - 805
  • [29] Spontaneous clearance of hepatitis C virus during pregnancy
    Clohessy, Penelope
    Polis, Suzanne
    Post, Jeffrey
    OBSTETRIC MEDICINE, 2013, 6 (01) : 28 - 29
  • [30] Statins and Risk of Decompensation in Hepatitis B Virus-Related and Hepatitis C Virus-Related Cirrhosis: Methodological Issues REPLY
    Chang, Fu-Ming
    Wang, Yen-Po
    Lu, Ching-Liang
    HEPATOLOGY, 2018, 67 (03) : 1174 - 1175